A Novel Immune-Related Four-Gene Signature for Prognosis and Immune Infiltration in Lung Adenocarcinoma
Frontiers in Medical Science Research · 2026 · 8 (2)
DOI: 10.25236/fmsr.2026.080207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medical Science Research, 2026.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality worldwide, highlighting an urgent need for robust prognostic biomarkers to guide clinical decision-making. In this study, we integrated single-cell RNA sequencing (GSE131907) with bulk transcriptomic data from The Cancer Genome Atlas (TCGA)-LUAD cohort to construct an immune-related prognostic signature. Through comprehensive analysis of 86,145 single cells, we established a LUAD atlas and identified immune-related genes by intersecting single-cell markers with the ImmPort database. Univariate Cox regression and LASSO penalized Cox analysis revealed a four-gene signature comprising PITX3, DKK1, TLE1, and LDHA, which stratified patients into high- and low-risk groups with significantly different overall survival outcomes (Log-rank P < 0.001). The signature exhibited robust predictive accuracy with area under the curve values of 0.713, 0.695, and 0.640 for 1-, 3-, and 5-year survival, respectively. Immune infiltration analysis using the xCell algorithm demonstrated that the low-risk group was enriched with anti-tumor immune cells, including CD8+ T cells and dendritic cells, while the high-risk group showed higher infiltration of immunosuppressive components. Furthermore, the risk score was positively correlated with immune checkpoint molecules such as PDCD1 and LAG3, suggesting an association with T-cell exhaustion and immune evasion. In summary, this four-gene immune-related signature serves as a promising prognostic biomarker for LUAD, offering valuable insights into the tumor immune microenvironment and potential implications for personalized immunotherapy strategies.
Zitieren
APA
(2026). A Novel Immune-Related Four-Gene Signature for Prognosis and Immune Infiltration in Lung Adenocarcinoma. Frontiers in Medical Science Research, 8(2). https://doi.org/10.25236/fmsr.2026.080207
Vancouver
A Novel Immune-Related Four-Gene Signature for Prognosis and Immune Infiltration in Lung Adenocarcinoma. Frontiers in Medical Science Research. 2026;8(2). doi:10.25236/fmsr.2026.080207
BibTeX
@article{euvimed2026,
title = {A Novel Immune-Related Four-Gene Signature for Prognosis and Immune Infiltration in Lung Adenocarcinoma},
journal = {Frontiers in Medical Science Research},
year = {2026},
volume = {8},
number = {2},
doi = {10.25236/fmsr.2026.080207}
}
EUVIMED